Mironid Limited

Activities: Research & Development

Trending Articles

  1. RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows...
  2. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  3. AstraZeneca to progress development of Quell Therapeutics' IBD Treg AstraZeneca will now perform IND-enabling studies on the cell therapy candidate, facilitating its clinical development
  4. EU GMP Annex 1 (August 2022): impact on cleaning and disinfection Cleaning and microbial contamination control are critical focus areas in the pharmaceutical and medical device industries. Robust cleaning and disinfection programmes are...
  5. Watson-Marlow Fluid Technology Solutions launches WMArchitect Interchangeable Parts Interchangeable Parts incorporates pre-qualified, alternative components in the design stage of your single-use assembly

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

Related Content

Manufacturing

Mironid advances finances for small molecule development

Mironid has raised $43.3 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease
Research & Development

Mironid and University of Sheffield collaborate on kidney disease drug discovery

Partnership will focus on the development of new therapeutics for autosomal dominant polycystic kidney disease
Subscribe now